Still on OpenSSL 1.0.2? SafeLogic has strategic options for Premium Extended Support and migration to the first OpenSSL 3.0 FIPS Provider. LEARN MORE!
Originally founded as CardioNet in 1994, the fledgling company hit another gear in their growth in the mid-2000s, making their first acquisition in 2007 and then successfully going public in 2008. CardioNet announced a merger with BioTel in 2010, but it wasn't until 2013 that the combined company, bolstered by acquisitions of ECG Scanning & Medical Services and CardioCore Lab, reincorporated under the BioTelemetry name.
BioTelemetry remains committed to leading the mobile and wireless medical technology industry. They focus on the delivery of health information to save and improve lives, while reducing the cost of care. Their ability to invent and share ideas and technologies with others ensures that customers and patients receive the very best in care. Today, BioTelemetry provides cardiac and mobile blood-glucose monitoring, centralized medical imaging and original equipment manufacturing serving the healthcare and clinical research sectors.
BioTel Heart encompasses the CardioNet, LifeWatch, Mednet, Heartrak, and Braemar brands and represents the next generation technology that will continue to fuel BioTelemetry's long term growth as part of Philips after a merger in early 2021. SafeLogic is proud to provide FIPS 140-2 validated encryption and services to this key partner in the healthcare sector!